How Transnational Civil Society Realized the Ban Treaty: An Interview with Beatrice Fihn
Journal for Peace and Nuclear Disarmament · 2018
DOI: 10.1080/25751654.2018.1441583 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for Peace and Nuclear Disarmament, 2018. Verfasst von Motoko Mekata. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIST Program, Department of Science and Technology, Govt. of India, Department of Science & Technology, Government of India.
Abstract (Originalsprache)
The International Campaign to Abolish Nuclear Weapons (ICAN) was awarded the Nobel Peace Prize in 2017. ICAN is a global coalition of non-governmental organizations in over 100 countries and was honored for its efforts to advance the Treaty on the Prohibition of Nuclear Weapons. Beatrice Fihn has been the Executive Director of ICAN, since 2014. During her Nobel Peace Prize speech, she said, “Together we have brought democracy to disarmament and are reshaping international law.” This interview took place in Nagasaki City on 14 January 2018. She expressed her views on the role of transnational civil society and discussed the democratization of the disarmament process more broadly.
Förderung
- FIST Program, Department of Science and Technology, Govt. of India
- Department of Science & Technology, Government of India
Zitieren
APA
Mekata, M. (2018). How Transnational Civil Society Realized the Ban Treaty: An Interview with Beatrice Fihn. Journal for Peace and Nuclear Disarmament. https://doi.org/10.1080/25751654.2018.1441583
Vancouver
Mekata M. How Transnational Civil Society Realized the Ban Treaty: An Interview with Beatrice Fihn. Journal for Peace and Nuclear Disarmament. 2018. doi:10.1080/25751654.2018.1441583
BibTeX
@article{Mekata2018,
author = {Mekata, Motoko},
title = {How Transnational Civil Society Realized the Ban Treaty: An Interview with Beatrice Fihn},
journal = {Journal for Peace and Nuclear Disarmament},
year = {2018},
doi = {10.1080/25751654.2018.1441583}
}
EUVIMED